SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-12-070066
Filing Date
2012-02-21
Accepted
2012-02-21 13:56:00
Documents
4
Period of Report
2012-02-14
Filing Date Changed
2012-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d304849d8k.htm 8-K 15855
2 PRESS RELEASE d304849dex991.htm EX-99.1 7528
3 GRAPHIC g304849g43d97.jpg GRAPHIC 19433
4 GRAPHIC g304849g63t17.jpg GRAPHIC 16167
  Complete submission text file 0001193125-12-070066.txt   74186
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-17264-NY | Film No.: 12626193
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1